Skip to content
XPR
content.
Press releases
Video
Podcasts
Op-eds
Lists
Guest posts
Author:
eXoZymes
eXoZymes to Host Second Quarter 2026 Update Conference Call on Thursday, August 20, 2026
August 11, 2026
eXoZymes Selected for DoE’s Genesis Mission to Advance AI-Powered Digital Twins for Cell-Free Biomanufacturing
July 23, 2026
eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery
June 24, 2026
eXoZymes Inc. Announces Closing of $6 Million Public Offering
June 17, 2026
eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants
June 8, 2026